Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine for moderate to severe acute pain after orthopedic surgery
ChiCTR2400081434Phase 4Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and hydromorphone in acute postoperative pain (3 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Area under the curve of pain score at rest from 0 to 72 hours after surgery. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
oliceridinehydromorphone
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2400081434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081434.